While reporting financial results for the first quarter on Friday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) raised its adjusted earnings and net revenue guidance for the full-year 2026.
For fiscal 2026, the company now projects adjusted earnings in the range of $9.19 to $9.69 per share on net revenues between $1.080 billion and $1.140 billion.
Previously, the company expected adjusted earnings in the range of $8.83 to $9.34 per share on net revenues between $1.055 billion and $1.115 billion.
Effective on May 8, 2026, ANIs board of directors authorized a new share repurchase program to repurchase up to $100.0 million in common stock through May 2029.
In Friday's pre-market trading, ANIP is trading on the Nasdaq at $89.94, up $6.03 or 7.19 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.